Atlas Genetics has developed a point-of-care device for Chlamydia trachomatis utilizing a novel electrochemical detection principle. The assay has a time-to-result of less than 25 min. An independent preclinical validation study using 306 pretyped clinical samples determined a clinical sensitivity of 98.1% and specificity of 98.0%.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187616 | PMC |
| http://dx.doi.org/10.1109/TBME.2010.2095851 | DOI Listing |
Publication Analysis
Top Keywords
novel electrochemical
8
electrochemical detection
8
chlamydia trachomatis
8
evaluation novel
4
detection method
4
method chlamydia
4
trachomatis application
4
application point-of-care
4
point-of-care diagnostics
4
diagnostics atlas
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!